UWM and Duke startup T3 BioScience successfully concludes its planned capital increase on July 25, 2017 – accelerating its R&D development plans Milwaukee, August 1, 2017 – T3 BioScience announces the successful closure of its capital increase on July 25, 2017. The (undisclosed) raised capital will empower the biotech firm to execute its product and business strategy.